Head, National Clinical Trials Network Clinical Trials Operations
Cancer Therapy Evaluation Program, National Cancer Institute
Andrea Denicoff, MS, RN, is Head of Clinical Trials Operations for the National Clinical Trials Network (NCTN) within the Cancer Therapy Evaluation Program in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI). She directs efforts to reduce barriers to clinical trial accrual and increase participation of diverse populations in cancer trials, including racial and ethnic minorities, the elderly, and adolescent and young adults. She directs components of the NCI’s Cancer Trials Support Unit that deals with accrual to NCTN trials, including the creation of national coverage analyses. She provides scientific review, leadership, and coordination for patient reported outcomes (PROs) in cancer treatment studies and is part of the PRO—Common Terminology Criteria for Adverse Events leadership team. She oversees NCI’s Informed Consent Template updates and ensures adherence to plain language principles to enhance health literacy. Before coming to the NCI, she was on the faculty at Georgetown University in the Department of Medicine, Division of Hematology/Oncology as an oncology nurse practitioner, and was active in the breast cancer clinical research program. Prior to that, she was the research nurse coordinating early phase breast cancer trials in NCI’s intramural program.
Thursday, November 15
10:30 AM – 11:45 AM